2019
DOI: 10.1007/s00345-019-02953-x
|View full text |Cite
|
Sign up to set email alerts
|

Novices in MRI-targeted prostate biopsy benefit from structured reporting of MRI findings

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Structured reporting has been shown to improve the accuracy of tumour localization and reduce the frequency of errors made during the performance of MRIguided biopsies. 73 The standard localization of any lesions for biopsy on the PI-RADS v2 sector map and with series and image numbers included in the report aids localization in MR/ultrasound fusion biopsy, as do either illustrations, annotated images or 3D contouring. 74 The Working Group thus recommends either fully structured or hybrid structured reporting (see Appendix E Sample Reporting Template) using the PI-RADS v2.1 reporting system.…”
Section: Reportingmentioning
confidence: 99%
“…Structured reporting has been shown to improve the accuracy of tumour localization and reduce the frequency of errors made during the performance of MRIguided biopsies. 73 The standard localization of any lesions for biopsy on the PI-RADS v2 sector map and with series and image numbers included in the report aids localization in MR/ultrasound fusion biopsy, as do either illustrations, annotated images or 3D contouring. 74 The Working Group thus recommends either fully structured or hybrid structured reporting (see Appendix E Sample Reporting Template) using the PI-RADS v2.1 reporting system.…”
Section: Reportingmentioning
confidence: 99%
“…In the first two articles, Ivo Shoots and colleagues review the role of multivariate risk prediction models without and with formal integration of MRI in making the diagnosis of clinically significant prostate cancer; a timely topic that has only recently been the subject of several important studies in this journal [10,11]. The submission by Narayan adds to this a critical assessment of individual biomarkers that have recently become available to arrive at 'smarter' screening for prostate cancer [12].…”
mentioning
confidence: 99%